Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation

Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation

Objective and;To evaluate the clinical value of valganciclovir in preemptive treatment of cytomegalovirus (CMV) infection after allogeneic hematopoietic stem cell transplantation (allo-HSCT) by comparing the efficacy of the drug with other conventional antiviral drugs (ganciclovir or foscarnet sodiu...

Full description

Bibliographic Details
Main Authors:	LU Xuan, YAN Han, XIA Linghui
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Third Military Medical University 2020-09-01
Series:	Di-san junyi daxue xuebao
Subjects:	cytomegalovirus viremia allogeneic hematopoietic stem cell transplantation valganciclovir preemptive therapy antithymocyte globulin
Online Access:	http://aammt.tmmu.edu.cn/Upload/rhtml/202005126.htm

Similar Items

Cytomegalovirus management after allogeneic hematopoietic stem cell transplantation: A mini-review
by: Chieh-Lin Jerry Teng, et al.
Published: (2021-06-01)

Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation
by: Ümit Özçelik, et al.
Published: (2020-01-01)

Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant Patients with Valganciclovir-Induced Leukopenia
by: Arindam Singha, et al.
Published: (2021-04-01)

Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab
by: Jorge Andrade-Sierra, et al.
Published: (2021-06-01)

The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia
by: A A Ganapiyev, et al.
Published: (2010-07-01)

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis
by: Siavash Vaziri, et al.
Published: (2014-01-01)

Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir
by: Tiziana Larussa, et al.
Published: (2012-11-01)

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC
by: Florent Malard, et al.
Published: (2018-10-01)

Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial
by: Tomas Reischig, et al.
Published: (2018-11-01)

Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation
by: Taeyun Kim, et al.
Published: (2020-03-01)

Role of oral valganciclovir in sick preterm with cytomegalovirus virus infection and ventilation dependence
by: Anumodan Gupta, et al.
Published: (2019-01-01)

Role of antithymocyte globulin in reducing the incidence of complications after allogeneic hemopoietic cell transplantation
by: Yu R Zalyalov, et al.
Published: (2010-08-01)

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
by: Restelli U, et al.
Published: (2019-05-01)

Mutations in the cytomegalovirus UL97 gene associated with ganciclovir resistance in recipients of allogeneic hematopoietic stem cell transplants
by: Demin M.V., et al.
Published: (2019-12-01)

Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience
by: Vipul Sheth, et al.
Published: (2019-07-01)

Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma
by: Giuseppe Stragliotto, et al.
Published: (2020-09-01)

Cytomegalovirus Infection in Kidney Transplant Recipients
by: Dino Šisl, et al.
Published: (2021-04-01)

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies
by: Xuan Li, et al.
Published: (2012-08-01)

Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
by: Dominika Deborska-Materkowska, et al.
Published: (2018-04-01)

Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma
by: Pantalone, M.R, et al.
Published: (2022)

Antithymocyte Globulin Induces a Tolerogenic Phenotype in Human Dendritic Cells
by: Tobias Roider, et al.
Published: (2016-12-01)

Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications
by: G. R. Pourmand, et al.
Published: (2012-04-01)

Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
by: El Helou G, et al.
Published: (2019-06-01)

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
by: Masoud Mardani, et al.
Published: (2020-12-01)

Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection
by: Shohei Ohyama, et al.
Published: (2019-03-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Risk factors of CMV replication after allogeneic hematopoietic stem cell transplantation in children and adolescents
by: S. N. Shiriaev, et al.
Published: (2014-09-01)

Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
by: Ren Lin, et al.
Published: (2019-08-01)

Long-Term Clinical, Audiological, Visual, Neurocognitive and Behavioral Outcome in Children With Symptomatic and Asymptomatic Congenital Cytomegalovirus Infection Treated With Valganciclovir
by: Arianna Turriziani Colonna, et al.
Published: (2020-07-01)

Conditioning Regimens in Allogeneic Hematopoietic Stem Cell Transplantation
by: Betul Tavil
Published: (2014-02-01)

Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
by: Susanne Jung, et al.
Published: (2019-05-01)

Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis
by: Xue Yang, et al.
Published: (2021-08-01)

Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium
by: Isa F. Ashoor, et al.
Published: (2021-04-01)

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
by: Eolia Brissot, et al.
Published: (2020-07-01)

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
by: Lauren Stern, et al.
Published: (2019-05-01)

Development of multifocal leukoencephalopathy in patients undergoing allogeneic stem cell transplantation—can preemptive detection of John Cunningham virus be useful?
by: Irit Avivi, et al.
Published: (2014-09-01)

Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data
by: Jillian Murray, et al.
Published: (2020-11-01)

Presumed cytomegalovirus retinitis in a non-immune compromised patient with breast carcinoma during treatment: A case report
by: Chia-Chen Kao, et al.
Published: (2021-09-01)

Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation
by: Ulrich Jehn, et al.
Published: (2020-01-01)

The risk factors for cytomegalovirus reactivation following stem cell transplantation
by: Bahareh Valadkhani, et al.
Published: (2016-01-01)